Prognostic significance of serum vascular endothelial growth factor and endostatin in patients with hepatocellular carcinoma
Open Access
- 7 July 2004
- journal article
- research article
- Published by Oxford University Press (OUP) in British Journal of Surgery
- Vol. 91 (10), 1354-1360
- https://doi.org/10.1002/bjs.4594
Abstract
High VEGF associated with worse survivalKeywords
Funding Information
- Committee on Research and Conferences Grant of the University of Hong Kong
This publication has 37 references indexed in Scilit:
- Prognostic impact of matched preoperative plasma and serum VEGF in patients with primary colorectal carcinomaBritish Journal of Cancer, 2002
- Vascular endothelial growth factor: its prognostic, predictive, and therapeutic implicationsThe Lancet Oncology, 2001
- Clinical Implications of Circulating Angiogenic Factors in Cancer PatientsJournal of Clinical Oncology, 2001
- Prognostic Significance of Vascular Endothelial Growth Factor Protein Levels in Oral and Oropharyngeal Squamous Cell CarcinomaJournal of Clinical Oncology, 2000
- Elevation of serum level of vascular endothelial growth factor as a new predictor of recurrence and disease progression in patients with superficial urothelial cancerUrology, 1999
- Expression of vascular endothelial growth factor correlates with hematogenous recurrence in gastric carcinomaSurgery, 1999
- Vascular endothelial growth factor is of high prognostic value in node-negative breast carcinoma.Journal of Clinical Oncology, 1998
- Vascular endothelial growth factor expression in non-small-cell lung cancer: Prognostic significance in squamous cell carcinomaThe Journal of Thoracic and Cardiovascular Surgery, 1998
- Vessel Counts and Expression of Vascular Endothelial Growth Factor as Prognostic Factors in Node-Negative Colon CancerArchives of Surgery, 1997
- Clinical Applications of Research on AngiogenesisNew England Journal of Medicine, 1995